18.737 articles found

Ablation of Mitochondrial RCC1-L Induces Nigral Dopaminergic Neurodegeneration and Parkinsonian-like Motor Symptoms

Ellioff KJ, Osting SM, Lentine A, Welper AD, Burger C, Greenspan DS.

· 2023-12-04

DOI: 10.1101/2023.12.01.567409

The effect of doorway characteristics on freezing of gait in Parkinson's disease.

Cockx HM, Lemmen EM, van Wezel RJA, Cameron IGM.

Front Neurol · 2023-12-04

DOI: 10.3389/fneur.2023.1265409PMID: 38111795

A meta-analysis identifies factors predicting the future development of freezing of gait in Parkinson's disease.

Herman T, Barer Y, Bitan M, Sobol S, Giladi N, Hausdorff JM.

NPJ Parkinsons Dis · 2023-12-04

DOI: 10.1038/s41531-023-00600-2PMID: 38049430

HD-tDCS Over Left Supplementary Motor Area Differentially Modulated Neural Correlates of Motor Planning for Speech vs. Limb Movement

Tabari F, Patron C, Cryer H, Johari K.

· 2023-12-03

DOI: 10.31234/osf.io/gqwua

Eye movements in Parkinson's disease: from neurophysiological mechanisms to diagnostic tools.

Antoniades CA, Spering M.

Trends Neurosci · 2023-12-02

DOI: 10.1016/j.tins.2023.11.001PMID: 38042680

DETERMINATION OF OPTIMAL VIBRATION DOSE TO TREAT PARKINSON’S DISEASE GAIT SYMPTOMS: A CLINICAL TRIAL

Check source for author details

Innovation in aging · 2023-12-01

Beta-triggered adaptive deep brain stimulation during reaching movement in Parkinson's disease.

He S, Baig F, Merla A, Torrecillos F, Perera A, Wiest C, Debarros J, Benjaber M, Hart MG, Ricciardi L, Morgante F, Hasegawa H, Samuel M, Edwards M, Denison T, Pogosyan A, Ashkan K, Pereira E, Tan H.

Brain · 2023-12-01

DOI: 10.1093/brain/awad233PMID: 37433037

Bexarotene improves motor function after spinal cord injury in mice.

Wang X, Shen Z, Zhang H, Zhang HJ, Li F, Yu L, Chen H, Zhou K, Xu H, Sheng S.

Neural Regen Res · 2023-12-01

DOI: 10.4103/1673-5374.373676PMID: 37449638

The Effect of the Human Brainstem Myelination on Gait Speed in Normative Aging.

Akhonda MABS, Faulkner ME, Gong Z, Laporte JP, Church S, D'Agostino J, Bergeron J, Bergeron CM, Ferrucci L, Bouhrara M.

J Gerontol A Biol Sci Med Sci · 2023-12-01

DOI: 10.1093/gerona/glad193PMID: 37555749

Imbalanced motivated behaviors according to motor sign asymmetry in drug-naïve Parkinson's disease.

Béreau M, Castrioto A, Servant M, Lhommée E, Desmarets M, Bichon A, Pélissier P, Schmitt E, Klinger H, Longato N, Phillipps C, Wirth T, Fraix V, Benatru I, Durif F, Azulay JP, Moro E, Broussolle E, Thobois S, Tranchant C, Krack P, Anheim M.

Sci Rep · 2023-12-01

DOI: 10.1038/s41598-023-48188-0PMID: 38040775

MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson's disease.

Geng L, Gao W, Saiyin H, Li Y, Zeng Y, Zhang Z, Li X, Liu Z, Gao Q, An P, Jiang N, Yu X, Chen X, Li S, Chen L, Lu B, Li A, Chen G, Shen Y, Zhang H, Tian M, Zhang Z, Li J.

Mol Neurodegener · 2023-12-01

DOI: 10.1186/s13024-023-00686-5PMID: 38041169

A novel transcranial photobiomodulation device to address motor signs of Parkinson's disease: a parallel randomised feasibility study.

Herkes G, McGee C, Liebert A, Bicknell B, Isaac V, Kiat H, McLachlan CS.

EClinicalMedicine · 2023-12-01

DOI: 10.1016/j.eclinm.2023.102338PMID: 38094162